Zhu W - Search Results

1

miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer.

Liang G, Meng W, Huang X, Zhu W, Yin C, Wang C, Fassan M, Yu Y, Kudo M, Xiao S, Zhao C, Zou P, Wang Y, Li X, Croce CM, Cui R. Liang G, et al. Among authors: zhu w. Proc Natl Acad Sci U S A. 2020 Feb 25;117(8):4347-4357. doi: 10.1073/pnas.1917531117. Epub 2020 Feb 10. Proc Natl Acad Sci U S A. 2020. PMID: 32041891 Free PMC article.

2

Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer.

Zhu W, He J, Chen D, Zhang B, Xu L, Ma H, Liu X, Zhang Y, Le H. Zhu W, et al. PLoS One. 2014 Feb 11;9(2):e87780. doi: 10.1371/journal.pone.0087780. eCollection 2014. PLoS One. 2014. PMID: 24523873 Free PMC article.

3

Downregulation of miR-21 increases cisplatin sensitivity of non-small-cell lung cancer.

Xu L, Huang Y, Chen D, He J, Zhu W, Zhang Y, Liu X. Xu L, et al. Among authors: zhu w. Cancer Genet. 2014 May;207(5):214-20. doi: 10.1016/j.cancergen.2014.04.003. Epub 2014 Apr 13. Cancer Genet. 2014. PMID: 24906642

4

Differential expression of miR-125a-5p and let-7e predicts the progression and prognosis of non-small cell lung cancer.

Zhu WY, Luo B, An JY, He JY, Chen DD, Xu LY, Huang YY, Liu XG, Le HB, Zhang YK. Zhu WY, et al. Cancer Invest. 2014 Oct;32(8):394-401. doi: 10.3109/07357907.2014.922569. Epub 2014 Jun 19. Cancer Invest. 2014. PMID: 24945821

5

Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.

Zhu W, Zhou K, Zha Y, Chen D, He J, Ma H, Liu X, Le H, Zhang Y. Zhu W, et al. PLoS One. 2016 Apr 19;11(4):e0153046. doi: 10.1371/journal.pone.0153046. eCollection 2016. PLoS One. 2016. PMID: 27093275 Free PMC article.

6

Alantolactone promotes ER stress-mediated apoptosis by inhibition of TrxR1 in triple-negative breast cancer cell lines and in a mouse model.

Yin C, Dai X, Huang X, Zhu W, Chen X, Zhou Q, Wang C, Zhao C, Zou P, Liang G, Rajamanickam V, Wang O, Zhang X, Cui R. Yin C, et al. Among authors: zhu w. J Cell Mol Med. 2019 Mar;23(3):2194-2206. doi: 10.1111/jcmm.14139. Epub 2019 Jan 4. J Cell Mol Med. 2019. PMID: 30609207 Free PMC article.

7

Prognostic value of mutant p53, Ki-67, and TTF-1 and their correlation with EGFR mutation in patients with non-small cell lung cancer.

Zhu WY, Hu XF, Fang KX, Kong QQ, Cui R, Li HF, He JY, Zhang YK, Le HB. Zhu WY, et al. Histol Histopathol. 2019 Nov;34(11):1269-1278. doi: 10.14670/HH-18-124. Epub 2019 May 7. Histol Histopathol. 2019. PMID: 31062864

8

A Prediction Rule for Overall Survival in Non-Small-Cell Lung Cancer Patients with a Pathological Tumor Size Less Than 30 mm.

Zhu WY, Fang KX, He JY, Cui R, Zhang YK, Le HB. Zhu WY, et al. Dis Markers. 2019 May 2;2019:8435893. doi: 10.1155/2019/8435893. eCollection 2019. Dis Markers. 2019. PMID: 31191756 Free PMC article.

9

miR-196b-5p-mediated downregulation of FAS promotes NSCLC progression by activating IL6-STAT3 signaling.

Huang X, Xiao S, Zhu X, Yu Y, Cao M, Zhang X, Li S, Zhu W, Wu F, Zheng X, Jin L, Xie C, Huang X, Zou P, Li X, Cui R. Huang X, et al. Among authors: zhu w, zhu x. Cell Death Dis. 2020 Sep 22;11(9):785. doi: 10.1038/s41419-020-02997-7. Cell Death Dis. 2020. PMID: 32963220 Free PMC article.

10

Dissecting miRNA signature in colorectal cancer progression and metastasis.

Huang X, Zhu X, Yu Y, Zhu W, Jin L, Zhang X, Li S, Zou P, Xie C, Cui R. Huang X, et al. Among authors: zhu w, zhu x. Cancer Lett. 2021 Mar 31;501:66-82. doi: 10.1016/j.canlet.2020.12.025. Epub 2020 Dec 29. Cancer Lett. 2021. PMID: 33385486 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,287 results

Search Page

Filters